Multiple Sclerosis Agents

Random Miscellaneous Quiz

Can you name the Multiple Sclerosis Agents?

Quiz not verified by Sporcle

embed
 plays        
How to Play
HintAnswer
Tricyclic class
Prednisone class
Second line agent: RRMS. Reduced relapses & progression of disability
SE: Thyroid disorders, ITP (with fatal brain hemorrhage), infections.
Excreted by kidney: contraindicated in moderate to severe renal failure
Methotrexate class
Use: treatment of spasticity
Dalfampridine class
Daclizumab class
Modafinil class
Second line agent given IV monthy
Dose: IV infusion every 3 months
Use: Fatigue
IFN beta 1-b (Betaseron) class
Off line agent used in the treatment of acute attacks
MOA: Synthetic form of myelin basic PRO copolymer 1. Binds to MHC molecules. Competes w/ myelin antigens for presentation to T cells.
Mitoxantrone class
MOA: Purine analog
Baclofen class
Dose: 1250 mg/day PO for 3-5 days
SE: HR reduction of 10-20 bpm, occasionally bradyarrhythmias or AV block -- screen for cardiac dz (6 hr monitoring w/ first dose). Macular edema in 1% (reversible). Check varicella
MOA: Immune modulator, exact mechanism not known.
Venlafaxine class
HintAnswer
MOA: alkylating agent
SE: Seizures at higher than recommended doses (contraindicated in pts with a hx of seizure)
Second line agent MOA: monoclonal Ab
Dose: Oral daily (first PO MS drug)
Plasmapheresis class
Methylphenidate class
MOA: Anti-organ rejection drug
Dose: IM weekly
Second line agent: RRMS, SPMS, Progressive Relapsing MS
Duloxetine class
SE: Inj site rxn w/ high doses, flu-like s/s (responds well to naproxen), monitor liver fx, may develop neutralizing Ab, may increase depression.
MOA: Immunomodulator/antineoplastic
MOA: Potassium channel blocker. Possibly increases conduction in demyelinated axons
Dose: SC injection 2-3 times weekly
Axathioprine class
Second line agent for RRMS that produces reduction in progression of disabilty
Dose: SC injection every other day
Tizanidine class
First line drugs for disease modification
MOA: Antimetabolite and antifolate
MOA: Sphingosine 1-phosphate receptor modulator. Sequesters lymphocytes.
IFN beta 1-a (Rebif) class
Methylprednisone class
HintAnswer
Alemtizumab class
SE: Localized inj site reactions. Self-limited (15-20 min) acute rxn resembling a panic attack (palpitations, dyspnea, flushing) -- not an indication to stop tx
Glatiramer acetate class
Use: Fatigue, cognitive impairment (long acting agent)
Use: For pts who do not respond to corticosteroids during acute attacks
Use: pain and paroxysmal disorders
Natalizumab class
Use: Depression. Also helps with pain
Use: Depression. Also helps with fatigue
Fingolimod class
SE: Risk of progressive multifocal leukoencephalopathy. Rare fatal viral (polymyxoma JC virus) reactivation infxn affecting white matter in immunosuppressed (only a risk to pts w/
MOA: Monoclonal Ab. Shows functional improvement not just slowing of decline
Carbamazepine class
Rituximab class
Gabapentin class
Bupropion class
First line RRMS agent injected SC daily
Mycophenolate class
Dose: 1 gram/day IV for 3-5 days
IFN beta 1-a (Avonex) class
Cyclophosphamide class
Dose: Oral. In extreme cases intrathecal

You're not logged in!

Compare scores with friends on all Sporcle quizzes.
Sign Up with Email
OR
Log In

You Might Also Like...

Show Comments

Extras